Altor Bioscience (Immunity Bio) Protocol: QUILT-3.032
- a study for patients with BCG unresponsive high-grade non-muscle invasive bladder cancer
Altor Bioscience (Immunity Bio) Protocol: QUILT-2.005
- a study for patients with high-grade non-muscle invasive bladder cancer who have never received BCG treatment
Myovant, Inc. Protocol: REPLACE_CV
- a study for patients being treated with Relugolix or Leuprolide Acetate.
Myovant, Inc. Protocol: Registry
- a registry study to collect patient satisfaction and compliance with Orgovyx
Gregor Diagnostics Protocol: GD001
- a study collecting semen samples in men scheduled for prostate biopsy
BPH-Benign Prostatic Hyperplasia (Enlarged Prostate):
ProVerum, Inc Protocol: The ProVIDE Study
- a device study for treating enlarged prostate in men age 45 and older.
Butterfly Medical Ltd Protocol: CL-BM14-001
- a device study for treating enlarged prostate in men 50-80.
Valencia Technologies Corporation Protocol: The Essence
- a study of an FDA approved device for treating urge incontinence.
EnGene INC Protocol: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- a study to test a medication in patients with non-muscle invasive bladder cancer